Riggs Asset Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-75
Closed -$279 679
2024
Q4
$279 Sell
75
-575
-88% -$2.58K ﹤0.01% 621
2024
Q3
$3.8K Buy
650
+20
+3% +$99 ﹤0.01% 311
2024
Q2
$2.72K Buy
630
+17
+3% +$81 ﹤0.01% 346
2024
Q1
$2.88K Buy
613
+96
+19% +$368 ﹤0.01% 327
2023
Q4
$2.54K Buy
517
+15
+3% +$73 ﹤0.01% 322
2023
Q3
$2.74K Buy
502
+14
+3% +$112 ﹤0.01% 329
2023
Q2
$4.51K Buy
488
+38
+8% +$321 ﹤0.01% 290
2023
Q1
$3.7K Buy
450
+100
+29% +$1.1K ﹤0.01% 277
2022
Q4
$3.9K Buy
+350
New +$4.07K ﹤0.01% 245
2017
Q3
Sell
-1,150
Closed -$15K 284
2017
Q2
$15K Hold
1,150
0.01% 207
2017
Q1
$15K Hold
1,150
0.01% 183
2016
Q4
$14K Hold
1,150
0.01% 183
2016
Q3
$17K Hold
1,150
0.01% 164
2016
Q2
$17K Hold
1,150
0.01% 165
2016
Q1
$15K Hold
1,150
0.01% 163
2015
Q4
$13K Hold
1,150
0.01% 180
2015
Q3
$13K Hold
1,150
0.01% 172
2015
Q2
$15K Hold
1,150
0.01% 194
2015
Q1
$17K Hold
1,150
0.01% 177
2014
Q4
$16K Buy
+1,150
New +$15.4K 0.01% 184

Other funds holding MPT

Riggs Asset Management's MPT Position: Q1 2025 in Review

Riggs Asset Management sold out of Medical Properties Trust (MPT) in Q1 2025, closing a stake of 75 shares — an estimated $279 sold.

Riggs Asset Management first reported a position in MPT in Q4 2014 and held it in 20 quarters. The position peaked at $17K in Q3 2016. 470 funds tracked by Wall St. Rank hold MPT as of Q1 2025.

  • Riggs Asset Management reported no remaining Medical Properties Trust position as of Q1 2025 after selling out during the quarter.
  • Riggs Asset Management sold 75 Medical Properties Trust shares in Q1 2025, an estimated $279.
  • Riggs Asset Management first reported a position in Medical Properties Trust in Q4 2014 and held it in 20 quarters.
  • Riggs Asset Management's Medical Properties Trust position peaked at $17K in Q3 2016.
  • 470 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2025.

Based on Riggs Asset Management's 13F filing for Q1 2025, filed 29 Apr 2025.